(125)I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma

AIM: To investigate the inhibitory efficacy of (125)I-labeled anti-basic fibroblast growth factor (bFGF) monoclonal antibody (mAb) in hepatocellular carcinoma (HCC). METHODS: bFGF mAb was prepared by using the 1G9B9 hybridoma cell line with hybridization technology and extracted from ascites fluid t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:World J Gastroenterol
Autors principals: Hu, Peng-Hui, Pan, Lan-Hong, Wong, Patrick Ting-Yat, Chen, Wen-Hui, Yang, Yan-Qing, Wang, Hong, Xiang, Jun-Jian, Xu, Meng
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Inc 2016
Matèries:
Basic Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4886378/
https://ncbi.nlm.nih.gov/pubmed/27275095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i21.5033
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars